Skip to main content
Log in

Effect of different doses of naloxone on serum levels of prolactin and gonadotropins in young male volunteers

  • Comment
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The dose-response of serum prolactin (PRL) values to different doses of naloxone (NAL) in rats is bellshaped. To test the effect of different doses of NAL on serum FSH, LH and PRL in humans these hormones were measured in 4 male volunteers after subject blind infusion of 0.02, 0.2 and 0.5 mg/kg NAL in random order. A saline infusion served as control. On each occasion an adjusted volume of 100 ml was infused within 10 min via an antecubital vein. Consequently blood samples were taken every 15 min for 4 h. To compare the response to the different treatments for each hormone the average of an individual’s hormone values (4×16) was set to 100%. Values at each timepoint were expressed in relation to the volunteer’s mean. The means and SE of hormone values set to 100% were: LH = 5.7 ± 0.7 ng/ml; FSH = 3.1 ± 1.0 ng/ml and PRL = 186 + 37 μU/ml. NAL infusion did not affect FSH levels at any dose level. No overall effect of NAL on PRL levels was detectable. There was a significant difference in LH values between saline control and NAL infusions, although no significant difference could be detected between different doses of NAL. Higher doses of NAL merely sustained LH levels for a longer time period. Based on the data presented a short test is suggested for screening patients under different pathophysiological conditions for involvement of endogenous opioids in the regulation of LH secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bruni J.F., Van Vugt D., Marshall S., Meites J. Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci. 21: 461, 1977.

    Article  PubMed  CAS  Google Scholar 

  2. Janowsky D., Judd L., Huey L, Roitman N., Parker D. Naloxone effects on serum growth hormone and prolac tin in man. Psychopharmacol. 65: 95, 1979.

    Article  CAS  Google Scholar 

  3. Rubin P., Swezey S., Blaschke T. Naloxone lowers plasma prolactin in man. Lancet 1: 1293, 1979.

    Article  PubMed  CAS  Google Scholar 

  4. Morley J.E., Baranetsky N.G., Wingert T.D., Carlson H.E., Hershman J.M., Melmed S., Levin S.R., Jamison K.R., Weitzman R., Chang R.J., Varner A.A. Endocrine effects of Naloxone-induced opiate receptor blockade. J. Clin. Endocrinol. Metab. 50: 251, 1980.

    Article  PubMed  CAS  Google Scholar 

  5. Blankstein J., Reyes F.I., Winter J.S.D., Faiman C. Endorphins and the regulation of the human menstrual cycle. Clin. Endocrinol. (Oxf.) 14: 287, 1981.

    Article  CAS  Google Scholar 

  6. Grossman A., Moult P.J.A., Gaillard R.C., Delitala G., Toff W.D., Rees L.H., Besser G.M. The opioid control of LH and FSH release: Effects of a met-enkephalin analogue and naloxone. Clin. Endocrinol. (Oxf.) 74: 41, 1981.

    Article  Google Scholar 

  7. Lightman S.L., Jacobs H.S., Maguire A.K., McGarrick G., Jeffcoate S.L. Constancy of opioid control of luteinizing hormone in different pathophysiological states. J. Clin. Endocrinol. Metab. 52: 1260, 1981.

    Article  PubMed  CAS  Google Scholar 

  8. Shaar C.J., Frederickson R.C.A., Dininger N.B., Jackson L. Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin evidence for regulation by an endogenous opioid peptide in brain. Life Sci 27: 853, 1977.

    Article  Google Scholar 

  9. Keppel G. Design and analysis, ed. 2. Prentice-Hall, Englewood Cliffs, 1982.

    Google Scholar 

  10. SPSS User’s Guide McGraw-Hill, New York, 1983.

  11. Grossman A., Rees L.H. The neuroendocrinology of opioid peptides. Br. Med. Bull., 39: 83, 1983.

    PubMed  CAS  Google Scholar 

  12. Moult P. J. A., Grossman A., Evans J.M., Rees L.H., Besser G.M. The effect of naloxone on pulsatile gonadotrophin release in normal subjects. Clin. Endocrinol. (Oxf.) 14: 321, 1981.

    Article  CAS  Google Scholar 

  13. Grossman A. Brain opiates and neuroendocrine function. Clin. Endocrinol. Metab. 12: 725, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Berkowitz B.A., Ngai S.H., Hempstead J., Spector S. Disposition of naloxone: Use of a new radioimmunoas say. J. Pharmacol. Exp. Ther. 195: 499, 1975.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knuth, U.A., Nieschlag, E. Effect of different doses of naloxone on serum levels of prolactin and gonadotropins in young male volunteers. J Endocrinol Invest 8, 55–57 (1985). https://doi.org/10.1007/BF03350640

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350640

Key-words

Navigation